![Andrea Pfeifer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 10 M $ al 31/05/2026
Andrea Pfeifer was the founder of AC Immune SA, founded in 2003, serving as Chief Executive Officer & Director from 2016 to 2026.
Dr. Pfeifer is also the founder of Inventages II..
Dr. Pfeifer currently serves as Chairman at BioMedInvest AG.
I and AB2 Bio Ltd., as an Independent Member of the Supervisory Board at Symrise AG since 2011, and as a Professor at the University of Lausanne.
Former positions include Chairman at BioMedPartners AG, Member of the Supervisory Board at 2invest AG, Principal at Nestlé USA, Inc., and Head of Global Research at Nestlé Nespresso SA. Education includes a doctorate from Wuerzburg Schweinfurt University of Applied Sciences, conferred in 1984.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AC IMMUNE SA 3,77 % | 15/05/2026 | 3.834.288 ( 3,77 % ) | 10 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SYMRISE AG | Director/Miembro de la Junta | 01/05/2011 |
University of Lausanne
 University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
BioMedInvest AG I
 BioMedInvest AG I Investment ManagersFinance Acts as Venture Capital Fund | Presidente | - |
AB2 Bio SA
 AB2 Bio SA Pharmaceuticals: MajorHealth Technology Operates as a drug discovery and development company | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
| AC IMMUNE SA | Fundador | 11/06/2026 |
| 2INVEST AG | Director/Miembro de la Junta | 18/10/2012 |
Nestlé Nespresso SA
 Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Designs and manufactures espresso machines | Corporate Officer/Principal | - |
Inventages II
 Inventages II Investment ManagersFinance Acts as Venture Capital Fund | Fundador | - |
BioMedPartners AG
 BioMedPartners AG Investment ManagersFinance BioMedPartners invests in companies located in Switzerland, Germany and neighboring Western Europe. The firm focuses on biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies. It participates in seed and early stage capital transactions. It also makes follow-on investments and acts a lead or co-lead investor. | Presidente | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
2invest AG
 2invest AG Financial ConglomeratesFinance Operates as an investment holding company primarily investing in biotechnology | Finance |
AC Immune SA
 AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
Symrise AG
 Symrise AG Chemicals: SpecialtyProcess Industries Produces fragrances and flavorings for taste, nutrition, health & scents | Process Industries |
Nestlé USA, Inc.
 Nestlé USA, Inc. Agricultural Commodities/MillingProcess Industries Manufactures and supplies baking, coffee, beverages, pet care, bottled water, frozen meals & infant nutrition products | Process Industries |
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioMedInvest AG I
BioMedInvest AG I Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Nestlé Nespresso SA
Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Designs and manufactures espresso machines | Producer Manufacturing |
Wuerzburg Schweinfurt University of Applied Sciences
 Wuerzburg Schweinfurt University of Applied Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners invests in companies located in Switzerland, Germany and neighboring Western Europe. The firm focuses on biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies. It participates in seed and early stage capital transactions. It also makes follow-on investments and acts a lead or co-lead investor. | Finance |
Inventages II
Inventages II Investment ManagersFinance Acts as Venture Capital Fund | Finance |
AB2 Bio SA
AB2 Bio SA Pharmaceuticals: MajorHealth Technology Operates as a drug discovery and development company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
